696 related articles for article (PubMed ID: 8697470)
1. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
[TBL] [Abstract][Full Text] [Related]
2. Short-term and long-term role of platelet activating factor as a mediator of in vivo platelet aggregation.
Golino P; Ambrosio G; Ragni M; Pascucci I; Triggiani M; Oriente A; McNatt J; Buja LM; Condorelli M; Chiariello M
Circulation; 1993 Sep; 88(3):1205-14. PubMed ID: 8353882
[TBL] [Abstract][Full Text] [Related]
3. Experimental carotid stenosis and endothelial injury in the rabbit: an in vivo model to study intravascular platelet aggregation.
Golino P; Ambrosio G; Pascucci I; Ragni M; Russolillo E; Chiariello M
Thromb Haemost; 1992 Mar; 67(3):302-5. PubMed ID: 1641819
[TBL] [Abstract][Full Text] [Related]
4. A monoclonal antibody against rabbit tissue factor inhibits thrombus formation in stenotic injured rabbit carotid arteries.
Pawashe AB; Golino P; Ambrosio G; Migliaccio F; Ragni M; Pascucci I; Chiariello M; Bach R; Garen A; Konigsberg WK
Circ Res; 1994 Jan; 74(1):56-63. PubMed ID: 8261595
[TBL] [Abstract][Full Text] [Related]
5. ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteries.
Yao SK; Ober JC; McNatt J; Benedict CR; Rosolowsky M; Anderson HV; Cui K; Maffrand JP; Campbell WB; Buja LM
Circ Res; 1992 Jan; 70(1):39-48. PubMed ID: 1727687
[TBL] [Abstract][Full Text] [Related]
6. Experimental carotid thrombosis in the guinea pig.
Roux S; Carteaux JP; Hess P; Falivene L; Clozel JP
Thromb Haemost; 1994 Feb; 71(2):252-6. PubMed ID: 8191408
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effect of plasma-derived and recombinant human FVIIa in vitro and in a rabbit model.
Hedner U; Ljundberg J; Lund-Hansen T
Blood Coagul Fibrinolysis; 1990 Jun; 1(2):145-51. PubMed ID: 2130926
[TBL] [Abstract][Full Text] [Related]
8. Prevention of experimental carotid artery thrombosis by applaggin.
Rote WE; Mu DX; Roncinske RA; Frelinger AL; Lucchesi BR
J Pharmacol Exp Ther; 1993 Nov; 267(2):809-14. PubMed ID: 8246155
[TBL] [Abstract][Full Text] [Related]
9. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition.
Freund M; Mantz F; Nicolini P; Gachet C; Mulvihill J; Meyer L; Beretz A; Cazenave JP
Thromb Haemost; 1993 May; 69(5):515-21. PubMed ID: 8322274
[TBL] [Abstract][Full Text] [Related]
10. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
Ramjit DR; Lynch JJ; Sitko GR; Mellott MJ; Holahan MA; Stabilito II; Stranieri MT; Zhang G; Lynch RJ; Manno PD
J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of microarterial thrombosis by activated protein C in a rabbit model.
Arnljots B; Bergqvist D; Dahlbäck B
Thromb Haemost; 1994 Sep; 72(3):415-20. PubMed ID: 7855793
[TBL] [Abstract][Full Text] [Related]
12. Endothelium-derived relaxing factor modulates platelet aggregation in an in vivo model of recurrent platelet activation.
Golino P; Cappelli-Bigazzi M; Ambrosio G; Ragni M; Russolillo E; Condorelli M; Chiariello M
Circ Res; 1992 Dec; 71(6):1447-56. PubMed ID: 1423938
[TBL] [Abstract][Full Text] [Related]
13. Combination of inhibition of thrombin and blockade of thromboxane A2 synthetase and receptors enhances thrombolysis and delays reocclusion in canine coronary arteries.
Yao SK; Ober JC; Ferguson JJ; Anderson HV; Maraganore J; Buja LM; Willerson JT
Circulation; 1992 Dec; 86(6):1993-9. PubMed ID: 1451271
[TBL] [Abstract][Full Text] [Related]
14. Complete inhibition of endotoxin-induced coagulation activation in chimpanzees with a monoclonal Fab fragment against factor VII/VIIa.
Biemond BJ; Levi M; ten Cate H; Soule HR; Morris LD; Foster DL; Bogowitz CA; van der Poll T; Büller HR; ten Cate JW
Thromb Haemost; 1995 Feb; 73(2):223-30. PubMed ID: 7792734
[TBL] [Abstract][Full Text] [Related]
15. Antithrombotic effect of a recombinant von Willebrand factor, VCL, on nitrogen laser-induced thrombus formation in guinea pig mesenteric arteries.
Azzam K; Garfinkel LI; Bal dit Sollier C; Cisse Thiam M; Drouet L
Thromb Haemost; 1995 Feb; 73(2):318-23. PubMed ID: 7792749
[TBL] [Abstract][Full Text] [Related]
16. The effect of two-domain tissue factor pathway inhibitor on endotoxin-induced disseminated intravascular coagulation in rabbits.
Bregengård C; Nordfang O; Wildgoose P; Svendsen O; Hedner U; Diness V
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):699-706. PubMed ID: 8292719
[TBL] [Abstract][Full Text] [Related]
17. Nonpeptide glycoprotein IIb/IIIa inhibitors. 5. Antithrombotic effects of MK-0383.
Lynch JJ; Cook JJ; Sitko GR; Holahan MA; Ramjit DR; Mellott MJ; Stranieri MT; Stabilito II; Zhang G; Lynch RJ
J Pharmacol Exp Ther; 1995 Jan; 272(1):20-32. PubMed ID: 7815334
[TBL] [Abstract][Full Text] [Related]
18. The strong positive correlation between factor VII clotting activity using bovine thromboplastin and the activated factor VII level.
Kario K; Matsuo T; Asada R; Sakata T; Kato H; Miyata T
Thromb Haemost; 1995 Mar; 73(3):429-34. PubMed ID: 7667824
[TBL] [Abstract][Full Text] [Related]
19. A comparative evaluation of thromboxane receptor blockade, thromboxane synthase inhibition and both in animal models of arterial thrombosis.
Salvati P; Dho L; Ukmar G; Vaga L; Rimoldi O; Patrono C
J Pharmacol Exp Ther; 1994 Apr; 269(1):238-45. PubMed ID: 8169831
[TBL] [Abstract][Full Text] [Related]
20. Antithrombotic activity in vivo of SDZ 217-766, a low-molecular weight thrombin inhibitor in comparison to heparin.
Tapparelli C; Metternich R; Gfeller P; Gafner B; Powling M
Thromb Haemost; 1995 Apr; 73(4):641-7. PubMed ID: 7495072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
